Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Statistical analyses of predictors for the 5-year bPFS, p values

From: Treatment outcome of localized prostate cancer using transperineal ultrasound image-guided radiotherapy

Factor

p value

UA

MA

Age (< 75y vs ≥ 75y)

0.1942

0.2236

T stage

0.1384

0.1569

GSG (≤ 2 vs ≥ 3)

0.0706

0.0933

PSA at diagnosis

0.0098

0.0106

PSA just before EBRT (< 0.1 vs ≥ 0.1, ng/ml)

0.1435

0.1745

NAHT duration

0.6936

0.6884

RTPIFM status (yes vs no)

0.3853

0.9248

AHT duration

0.3326

0.3536

  1. The p values for which significant differences were detected are underlined
  2. bPFS, biological PSA-free survival; NAHT, neoadjuvant hormonal therapy; AHT, adjuvant hormonal therapy; UA, univariate analysis; MA, multivariate analysis
  3. Others as in Table 1
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us